{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:14:29Z","timestamp":1768270469064,"version":"3.49.0"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:p>Interleukin-6 (IL-6) is implicated in the pathogenesis of both systemic juvenile idiopathic arthritis (SJIA) and syndrome of inappropriate secretion of antidiuretic hormone (SIADH), but the 2 have not been previously described as occurring together. We report a case of a 6-year-old girl with symptoms of arthralgia, daily fevers, evanescent rash, lymphadenopathy, and laboratory evaluation showing elevated inflammatory markers, consistent with SJIA. At presentation, the patient had hyponatremia with a sodium level of 128 mEq\/L. She had low serum osmolality with elevated urine osmolality, consistent with SIADH. Hyponatremia improved temporarily during times of fluid restriction as expected in SIADH, but did not resolve until SJIA was treated successfully with tocilizumab, an IL-6 receptor antibody that inhibits IL-6 activity. The positive response to treatment with tocilizumab supports the role of IL-6 in the pathogenesis of both SJIA and SIADH. Patients with SJIA should be monitored for SIADH to avoid complications of untreated hyponatremia.<\/jats:p>","DOI":"10.1542\/peds.2016-4174","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T08:30:08Z","timestamp":1513240208000},"source":"Crossref","is-referenced-by-count":15,"title":["SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor"],"prefix":"10.1542","volume":"141","author":[{"given":"Juanita K.","family":"Hodax","sequence":"first","affiliation":[{"name":"Divisions of Pediatric Endocrinology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shara R.","family":"Bialo","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Endocrinology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Yalcindag","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2018,1,1]]},"reference":[{"issue":"20","key":"2021120916294348700_B1","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis.","volume":"356","author":"Ellison","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"2021120916294348700_B2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4070\/kcj.2010.40.10.507","article-title":"Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in Kawasaki disease.","volume":"40","author":"Lim","year":"2010","journal-title":"Korean Circ J"},{"issue":"4","key":"2021120916294348700_B3","first-page":"934","article-title":"Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.","volume":"79","author":"Mastorakos","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021120916294348700_B4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000322238","article-title":"Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation.","volume":"118","author":"Swart","year":"2011","journal-title":"Nephron Physiol"},{"issue":"2","key":"2021120916294348700_B5","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"2021120916294348700_B6","first-page":"343","article-title":"Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).","volume":"35","author":"Behrens","year":"2008","journal-title":"J Rheumatol"},{"issue":"3","key":"2021120916294348700_B7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2021120916294348700_B8","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1542\/peds.2006-1127","article-title":"Hyponatremia, hypophosphatemia, and hypouricemia in a girl with macrophage activation syndrome.","volume":"118","author":"Yamazawa","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"2021120916294348700_B9","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"2021120916294348700_B10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2004-2190","article-title":"Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis.","volume":"116","author":"Binstadt","year":"2005","journal-title":"Pediatrics"},{"key":"2021120916294348700_B11","first-page":"1","article-title":"Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease.","author":"Mizuta","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"5","key":"2021120916294348700_B12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jpeds.2015.02.003","article-title":"Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease.","volume":"166","author":"Dong","year":"2015","journal-title":"J Pediatr"},{"key":"2021120916294348700_B13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2017.01.068","article-title":"Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.","volume":"236","author":"Downie","year":"2017","journal-title":"Int J Cardiol"},{"issue":"25","key":"2021120916294348700_B14","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"2021120916294348700_B15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis.","volume":"34","author":"de Benedetti","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2021120916294348700_B16","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1152\/ajpendo.90489.2008","article-title":"Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in rats.","volume":"296","author":"Palin","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-4174\/1065683\/peds_20164174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2016-4174\/1065683\/peds_20164174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T04:42:18Z","timestamp":1639111338000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/141\/1\/e20164174\/37682\/SIADH-in-Systemic-JIA-Resolving-After-Treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,1]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2016-4174","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,1]]},"article-number":"e20164174"}}